Telkom Indonesia Trims the Fat: Healthcare Divestiture Signals a Return to Digital Roots
Key Takeaways
|
JAKARTA, Investortrust.id — PT Multimedia Nusantara, better known as TelkomMetra, has officially signed a conditional sale and purchase agreement (CSPA) to divest its entire stake in PT Administrasi Medika (AdMedika) to Fullerton Health. The move marks a decisive exit from the healthcare administration sector for the subsidiary of PT Telkom Indonesia (TLKM), the nation’s state-owned telecommunications titan.
The transaction is not merely a balance-sheet adjustment; it represents the latest maneuver in a sweeping restructuring of Indonesia’s state-owned enterprises (BUMN). Under the mandate of Danantara—the newly formed super-holding entity tasked with optimizing government assets—Telkom is under pressure to shed peripheral businesses to sharpen its focus on its "core" digital and telecommunications infrastructure.
This "streamlining" is a critical pillar of the "TLKM 30" transformation plan. As telecommunications firms globally struggle with the commoditization of data, Telkom is betting that a leaner corporate structure—focused on 5G, data centers, and digital services—will yield higher long-term valuations than the sprawling, multi-industry conglomerate model it favored in the previous decade.
The Strategic Pivot
Pramasaleh Haryo Utomo, President Director of TelkomMetra, described the divestiture as a "measured decision" grounded in corporate governance and long-term value creation. By offloading AdMedika and its subsidiary, TelkoMedika, TelkomMetra is handing over a technology-based third-party administrator (TPA) that has become a staple of the Indonesian corporate insurance landscape since its acquisition in 2010.
"The signing of the CSPA with Fullerton Health is a step toward full divestment," Pramasaleh said in an official statement. "It aligns with TelkomGroup's transformation to strengthen our focus on core business and long-term value creation."
A Regional Power Play
For Fullerton Health, the acquisition is an aggressive play for dominance in Southeast Asia’s largest economy. AdMedika currently operates the largest TPA network in Indonesia, providing claim management and integrated digital health services to a vast array of corporations and insurers.
Fullerton, which operates in nine countries and manages approximately 550 healthcare facilities, views AdMedika as the ideal vehicle to integrate its regional operational discipline with a deeply entrenched local platform.
"This acquisition reflects Fullerton Health’s commitment to strengthening our presence within the Indonesian healthcare landscape," said Ho Kuen Loon, Group CEO of Fullerton Health. He noted that AdMedika’s "digital innovation and clinical discipline" provide a robust foundation for regional expansion.
Legacy and Future Growth
AdMedika’s journey within the Telkom stable began 16 years ago. Since then, it has grown into a dominant player in the domestic managed-care market. However, as the healthcare and insurance sectors become increasingly competitive and specialized, analysts suggest that AdMedika’s growth had likely plateaued under the umbrella of a telecom-focused parent.
The synergy with Fullerton Health is expected to unlock new capital and regional networks, allowing AdMedika to scale beyond Indonesian borders. Meanwhile, for Telkom Indonesia, the cash infusion and reduced operational complexity allow the firm to double down on its roadmap for "Sovereign AI" and enhanced fiber-optic penetration through 2028.
The deal remains subject to customary closing conditions, after which Fullerton Health will assume full operational control of the AdMedika Group.

